Statistics
Publications
14
Citations
399
H-Index
11
Active since
2005
Xinglan Li is an author at Sichuan University specializing in oncology, molecular oncology, and gene expression.
Publications per year
2005–2024
14
14
SOX9 was involved in TKIs resistance in renal cell carcinoma via Raf/MEK/ERK signaling pathway.
Xinglan Li, Xueqin Chen, Mengni Zhang et al. · PubMed · 2015 · 29 citations
Medicine, Oncology, Pharmacology +17
Xinglan Li, Yueju Yin, Xui-gui Sheng et al. · Radiation Oncology · 2015 · 22 citations · Full text
1–5 of 14